Trial Profile
A preliminary double-blind, single-dose, placebo-controlled, crossover, randomized to evaluate the safety, tolerability and biobehavioral effects of idazoxan co-administered with alcohol in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Idazoxan (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Apr 2016 New trial record